Driehaus Capital Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Driehaus Capital Management's TWST Position: Q2 2026 in Review
Driehaus Capital Management increased its Twist Bioscience (TWST) stake by 75% in Q2 2026, buying an estimated $28.5M and bringing the position to 1,022,526 shares worth $105M. The position accounts for 0.61% of the portfolio, ranked #46.
Driehaus Capital Management first reported a position in TWST in Q4 2018 and has held it in 14 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Driehaus Capital Management held 1,022,526 shares of Twist Bioscience worth $105M as of Q2 2026.
- Driehaus Capital Management bought 437,830 Twist Bioscience shares in Q2 2026, an estimated $28.5M.
- Twist Bioscience made up 0.61% of Driehaus Capital Management's portfolio in Q2 2026, its #46 holding.
- Driehaus Capital Management first reported a position in Twist Bioscience in Q4 2018 and has held it in 14 quarters since.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.